JP2025106358A5 - - Google Patents

Info

Publication number
JP2025106358A5
JP2025106358A5 JP2025061016A JP2025061016A JP2025106358A5 JP 2025106358 A5 JP2025106358 A5 JP 2025106358A5 JP 2025061016 A JP2025061016 A JP 2025061016A JP 2025061016 A JP2025061016 A JP 2025061016A JP 2025106358 A5 JP2025106358 A5 JP 2025106358A5
Authority
JP
Japan
Prior art keywords
alkyl
group
membered
alkoxy
oxa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025061016A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025106358A (ja
Filing date
Publication date
Priority claimed from PCT/JP2023/000211 external-priority patent/WO2023132369A1/ja
Application filed filed Critical
Publication of JP2025106358A publication Critical patent/JP2025106358A/ja
Publication of JP2025106358A5 publication Critical patent/JP2025106358A5/ja
Pending legal-status Critical Current

Links

JP2025061016A 2022-01-07 2025-04-02 Nrf2活性化作用を有する含窒素複素環化合物 Pending JP2025106358A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2022001804 2022-01-07
JP2022001804 2022-01-07
PCT/JP2023/000211 WO2023132369A1 (ja) 2022-01-07 2023-01-06 Nrf2活性化作用を有する含窒素複素環化合物
JP2023572495A JP7661533B2 (ja) 2022-01-07 2023-01-06 Nrf2活性化作用を有する含窒素複素環化合物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2023572495A Division JP7661533B2 (ja) 2022-01-07 2023-01-06 Nrf2活性化作用を有する含窒素複素環化合物

Publications (2)

Publication Number Publication Date
JP2025106358A JP2025106358A (ja) 2025-07-15
JP2025106358A5 true JP2025106358A5 (cg-RX-API-DMAC7.html) 2026-01-13

Family

ID=87073790

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023572495A Active JP7661533B2 (ja) 2022-01-07 2023-01-06 Nrf2活性化作用を有する含窒素複素環化合物
JP2025061016A Pending JP2025106358A (ja) 2022-01-07 2025-04-02 Nrf2活性化作用を有する含窒素複素環化合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2023572495A Active JP7661533B2 (ja) 2022-01-07 2023-01-06 Nrf2活性化作用を有する含窒素複素環化合物

Country Status (17)

Country Link
US (2) US20250084093A1 (cg-RX-API-DMAC7.html)
EP (1) EP4446312A4 (cg-RX-API-DMAC7.html)
JP (2) JP7661533B2 (cg-RX-API-DMAC7.html)
KR (1) KR20240133727A (cg-RX-API-DMAC7.html)
CN (1) CN118488944A (cg-RX-API-DMAC7.html)
AR (1) AR128216A1 (cg-RX-API-DMAC7.html)
AU (1) AU2023204960A1 (cg-RX-API-DMAC7.html)
CA (1) CA3246898A1 (cg-RX-API-DMAC7.html)
CL (1) CL2024001687A1 (cg-RX-API-DMAC7.html)
CO (1) CO2024007707A2 (cg-RX-API-DMAC7.html)
CR (1) CR20240325A (cg-RX-API-DMAC7.html)
IL (1) IL312793A (cg-RX-API-DMAC7.html)
MX (1) MX2024008480A (cg-RX-API-DMAC7.html)
PE (1) PE20241779A1 (cg-RX-API-DMAC7.html)
TW (1) TW202340204A (cg-RX-API-DMAC7.html)
WO (1) WO2023132369A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202406044B (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CR20240325A (es) * 2022-01-07 2024-11-22 Chugai Pharmaceutical Co Ltd Compuesto heterocíclico que contiene nitrógeno que tiene un efecto de activación del nrf2
EP4696692A1 (en) * 2023-06-19 2026-02-18 Chugai Seiyaku Kabushiki Kaisha Crystal of nitrogen-containing heterocyclic compound having nrf2 activation effect
CN118221551A (zh) * 2024-04-10 2024-06-21 南京艾康生物科技有限公司 4-甲酰苄基氨基甲酸叔丁酯的制备方法
CN119684220A (zh) * 2024-12-13 2025-03-25 江苏宝众宝达药业股份有限公司 一种(2r,5r)-1,2,5-三甲基哌嗪的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6326507B1 (en) 1998-06-19 2001-12-04 Trustees Of Dartmouth College Therapeutic compounds and methods of use
CN102458402B (zh) * 2009-06-12 2013-10-02 百时美施贵宝公司 用作激酶调节剂的烟酰胺化合物
US20140256767A1 (en) * 2011-10-31 2014-09-11 The Broad Institute, Inc. Direct inhibitors of keap1-nrf2 interaction as antioxidant inflammation modulators
US9403774B2 (en) * 2012-10-12 2016-08-02 Bristol-Myers Squibb Company Guanidine and amine substituted tetrahydroisoquinoline compounds as factor xia inhibitors
TWI649330B (zh) 2013-04-24 2019-02-01 艾伯維有限公司 甲基巴多索龍之2,2-二氟丙醯胺衍生物、其多晶形及其使用方法
US10568876B2 (en) * 2014-09-05 2020-02-25 Merck Sharp & Dohme Corp. Tetrahydroisoquinoline derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2
US20190380992A1 (en) 2014-12-04 2019-12-19 Biogen Ma Inc. Multiple Sclerosis Treatment Regimen Using Dimethyl Fumarate
US20190389836A1 (en) * 2017-01-30 2019-12-26 Biogen Ma Inc. Nrf2 activator
CN110294744A (zh) 2018-03-21 2019-10-01 中国医学科学院药物研究所 Gpr40受体激动剂、其制法和其药物组合物与用途
MY207469A (en) * 2018-10-22 2025-02-27 C4X Discovery Ltd Therapeutic compounds
KR102932313B1 (ko) * 2019-02-15 2026-02-26 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 Nrf2 활성화제로서 히드록시피리드옥사제핀
GB202005863D0 (en) * 2020-04-22 2020-06-03 C4X Discovery Ltd Therapeutic compounds
GB202005852D0 (en) * 2020-04-22 2020-06-03 C4X Discovery Ltd Therapeutic compounds
CN114507181B (zh) * 2020-11-17 2024-03-26 中国医学科学院药物研究所 含5-取代四氢异喹啉的丙酸类化合物、其药物组合物和应用
CR20240325A (es) * 2022-01-07 2024-11-22 Chugai Pharmaceutical Co Ltd Compuesto heterocíclico que contiene nitrógeno que tiene un efecto de activación del nrf2

Similar Documents

Publication Publication Date Title
JPWO2023132369A5 (cg-RX-API-DMAC7.html)
JP2016517878A5 (cg-RX-API-DMAC7.html)
JPWO2020085493A5 (cg-RX-API-DMAC7.html)
JP2017515844A5 (cg-RX-API-DMAC7.html)
IL308165A (en) Pyrazolyl derivatives as inhibitors of the mutant Kras protein
RU2016146365A (ru) Новые дигидрохинолизиноны для лечения и профилактики заражения вирусом гепатита b
JP2013515070A5 (cg-RX-API-DMAC7.html)
JP2023523438A5 (cg-RX-API-DMAC7.html)
RU2012131129A (ru) Соединения замещенного n-(1н-индазол-4-ил)имидазол[1,2-а]-3-карбоксамида как ингибиторы cfms
JP2012503018A5 (cg-RX-API-DMAC7.html)
RU2006111583A (ru) Производные 1-(2-аминобензол)пиперазина, используемые в качестве ингибиторов поглощения глицина и предназначенные для лечения психоза
JP2009529047A5 (cg-RX-API-DMAC7.html)
JP2012501312A5 (cg-RX-API-DMAC7.html)
JP2013523884A5 (cg-RX-API-DMAC7.html)
JP6695353B2 (ja) Fgfr4阻害剤としてのホルミル化n−複素環式誘導体
JP2017505794A5 (cg-RX-API-DMAC7.html)
CA2749040A1 (en) Triazolo and tetrazolo pyrimidine derivatives as hne inhibitors for treating copd
RU2017112518A (ru) Пиридоновые и азапиридоновые соединения и способы применения
RU2016136116A (ru) Фармацевтические соединения
RU2011107437A (ru) Ингибиторы кинуренин-3-моноксигеназы
RU2009101911A (ru) Производные пиридина и пиразина в качестве ингибиторов mnk-киназы
JP2010510319A5 (cg-RX-API-DMAC7.html)
JP2007501831A5 (cg-RX-API-DMAC7.html)
JP2015514806A5 (cg-RX-API-DMAC7.html)
JP2019505595A5 (cg-RX-API-DMAC7.html)